Teva Pharmaceutical Industries Ltd interim cheif legal officer Dov Bergwerk sells $1.1M of TEVA shares
26,260 shares sold on the open market on Nov 4, at about $41.72 each. Information only, not investment advice.
Insider selling at Teva Pharmaceutical Industries Ltd: Dov Bergwerk, an interim cheif legal officer, sold 26,260 shares on Nov 4 for $1.1 million, at an average of $41.72 a share, a Form 4 filed on Nov 6 shows.
The filing does not mark the sale as made under a Rule 10b5-1 trading plan. The trade was reported within two business days, as Section 16 requires.
After the trade, the filing lists 11,943 shares held.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | Teva Pharmaceutical Industries Ltd (TEVA) |
|---|---|
| Insider | Dov Bergwerk |
| Role | Interim Cheif Legal Officer |
| Transaction | Open-market sale (code S) |
| Shares | 26,260 |
| Average price | $41.72 |
| Value | $1,095,567 |
| Trade date | Nov 4, 2026 |
| Filed with the SEC | Nov 6, 2026, 4:01 PM ET |
| Shares held after | 11,943 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See more details on this insider sale
See all insider activity at Teva Pharmaceutical Industries Ltd · Browse the latest insider selling
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
Related Articles
- Insider Trading News
Teva Pharmaceutical Industries Ltd officer Mark Sabag sells $1.93M in stock
- Insider Trading News
Three DuPont de Nemours, Inc. insiders sell $14.1M of stock in 5 days
- Insider Trading News
Carvana Co. director J. Danforth Quayle sells $1M of CVNA stock
- Insider Trading News
Aeva Technologies, Inc. insider Mina Rezk sells $248,537 in AEVA shares
- Insider Trading News
CEO Soroush Salehian Dardashti sells $372,827 of Aeva Technologies, Inc. stock